Phillip Scheinberg, MD

Articles by Phillip Scheinberg, MD

Dr. Scheinberg Highlights MDS, AML Abstracts at ASH 2023

Phillip Scheinberg, MDMyelodysplastic Syndromes | December 14, 2023

Dr. Schienberg discussed luspatercept in MDS, selinexor in AML, and the difficulty of randomizing trials.

Phillip Scheinberg, MD, Reports on MDS From the Eleventh Annual SOHO Meeting

Phillip Scheinberg, MDMyelodysplastic Syndromes | September 11, 2023

"There's been a lot of focus on classifications and mutations: they're coming with a lot of force," Dr. Scheinberg said.

The HemOnc Pulse Live at ASH: Phillip Scheinberg, MD, on CHIP, MDS Classification Updates

Chadi Nabhan, MD, MBA, FACPMeeting News | January 10, 2023

Phillip Scheinberg, MD, talk about CHIP and the IPSS-M in MDS with Chadi Nabhan, MD, host of The HemOnc Pulse, during ASH.